Study Areas


Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH. Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study. RMD Open. 2015;1(1):e000042. doi:10.1136/rmdopen-2014-000042

Zhang W, Bansback N, Sun H, Pedersen R, Kotak S, Anis AH. Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study. RMD Open. 2016;2(2):e000222. doi:10.1136/rmdopen-2015-000222


Sadatsafavi M, Rousseau R, Chen W, et al. The preventable burden of productivity loss due to suboptimal asthma control: a population-based study. Chest. 2014;145(4):787-793. doi:10.1378/chest.13-1619

Systemic Autoimmune Rheumatic Disease

McCormick N, Reimer K, Famouri A, Marra CA, Aviña-Zubieta JA. Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada. BMJ Open. 2017;7(6):e013977. doi:10.1136/bmjopen-2016-013977

McCormick N, Marra CA, Sadatsafavi M, Kopec JA, Aviña‐Zubieta JA. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren’s Syndrome: A General Population–Based Study. Arthritis Care & Research. 2019;71(1):142-154. doi:10.1002/acr.23573

Cardiovascular Diseases

CAMMPUS Cardiovascular Health Assessment Program - UBC Human Resources. Accessed January 13, 2019.

Gobis B, Kapanen AI, Reardon J, et al. Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and Medication Management by Pharmacists at the UBC Site). Ann Pharmacother. January 2019:1060028018823330. doi:10.1177/1060028018823330